NCT00250627View on ClinicalTrials.gov

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

465

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Depressive Disorder
Interventions
DRUG

Saredutant succinate (SR48968C)

Trial Locations (8)

Unknown

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Porto Salvo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00250627 - An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression | Biotech Hunter | Biotech Hunter